OrthoPediatrics Corp. provided revenue guidance for the fourth quarter and full year ended December 31, 2022 and fiscal year 2023. Preliminary unaudited fourth quarter 2022 net revenue is expected to be $31.0 million, representing growth of 25% compared to $24.8 million in the fourth quarter of 2021.
Preliminary unaudited full year 2022 net revenue is expected to be $122.3 million, representing growth of 25% compared to $98.0 million in 2021.
Management projects 2023 net revenue to be in the range of $146.0 million to $149.0 million, representing growth of 20% to 22% over 2022 preliminary unaudited net revenue.